Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 Next >
5 things to know before the stock market opens Tuesday
Tags Technology Business 5 Things to Know
From CNBC.com News
Weight loss drugs cut Covid-19 deaths, study finds
Tags Europe Markets Pharmaceuticals Business
From CNBC.com News
Eli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supply
Tags Pharmaceuticals Business Health & Science
From CNBC.com News
Health-care system Sesame to offer compounded versions of Wegovy through new $249 weight loss program
Tags Biotechnology Companies US: News
From CNBC.com News
Eli Lilly's weight loss drug slashes the risk of developing diabetes in long-term trial
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Health care industry
From CNBC.com News
What's next for the Biden administration's Medicare drug price negotiations
Tags Health care industry Bristol/Myers Squibb Co Biotech and Pharmaceuticals
From CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
Tags Merck & Co Inc Bristol/Myers Squibb Co Amgen Inc
From CNBC.com News
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
Tags Healthy Returns Health care industry Eli Lilly and Co
From CNBC.com News
Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs
Tags Companies US: News Biotechnology
From CNBC.com News
Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says
Tags Health care industry Eli Lilly and Co Novo Nordisk A/S
From CNBC.com News
Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage study
Tags Health care industry Eli Lilly and Co Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
Tags Health & Science Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
Tags Biogen Inc Biotechnology Companies
From CNBC.com News
Swiss pharma giant Roche to accelerate Wegovy rival drugs after positive trial data
Tags Biotechnology Business News Novo Nordisk A/S
From CNBC.com News
Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial
Tags Breaking news Business Pharmaceuticals
From CNBC.com News
Wegovy rival to be part of a suite of weight loss drugs, Roche CEO says following positive trial results
Tags Biotechnology Pharmaceuticals Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
Tags Novo Nordisk A/S Merck & Co Inc Biotech and Pharmaceuticals
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug wins UK approval for use as a heart treatment
Tags Health & Science Novo Nordisk A/S Health care industry
From CNBC.com News
Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche
Tags Business News Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
Tags Health & Science Pfizer Inc Merck & Co Inc
From CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Health & Science
From CNBC.com News
Pfizer moves forward with once-daily version of weight loss pill after setbacks
Tags Pharmaceuticals Business Companies
From CNBC.com News
Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'
Tags Stock markets stocks Investment Strategy
From CNBC.com News
FTC to sue drug middlemen over prices of medications including insulin
Tags Pharmaceuticals Business Sanofi SA
From CNBC.com News
CNBC Daily Open: French left-wing shock victory, Boeing guilty plea
Tickers LAWS
Tags Stock indices and averages Tesla Inc Economic policy
From CNBC.com News
CNBC Daily Open: French far-right advance blocked
Tags Tesla Inc Stock indices and averages Stock markets
From CNBC.com News
This ETF is trying to satisfy appetites for weight loss stocks
Tags Investment strategy Finance Markets
From CNBC.com News
Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
Tags Biotechnology Companies US: News
From CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
Tags Health & Science Altimmune Inc Gilead Sciences Inc
From CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Zealand Pharma A/S
From CNBC.com News
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.